Long-term morbidity rate is low. (LoE: III)
Technical advances improve tumor control and lower
toxicity.
Careful patient selection is important to avoid unacceptable
morbidity
Urgent need for prospective trials to investigate on medical
approaches to the treatment of morbidity.
Summary




